3Yu L X, Furness M S, Raw A, et al..Scientific considerations of pharmaceutical solid polymorphism in abbreviated new drug applications.Pharmaceutical Research, 2003, 20(4):531
6Toscani S, Thoren S, Agafonov V, et al. Thermodynamic study of sulfanilamide. Polymorphism: (Ⅰ) monotropy of the α- variety. Pharm Res, 1995, 12(10):1453
10Dharmendra Singhal, William Curatolo. Drug polymorphism and dosage form design: a practical perspective. Advanced Drug Delivery Reviews,2004,56 (3) :335
